We found that glioma cells secrete IL-33, a member of the IL-1 cytokine family that can exert its effects by binding and activating the cell surface receptor ST2 (ref. 48), and its downstream signaling pathways or by translocation to the nucleus to bind chromatin to regulate the gene transcription49,50. Here, IL33 is linked to central nervous system cancer.